---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-132699"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2025-06-02T23:59:59+00:00"
generated_at: "2026-05-20T02:56:51.981291+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Indivior posts updated corporate presentation June 2025; content not fully disclosed

## Summary
- Company added 'Corporate Presentation June 2025' to its investor relations website on June 2, 2025.
- Presentation furnished as Exhibit 99.1; full text not provided in SEC filing excerpt.
- No specific financial guidance, clinical data, or operational updates available from truncated exhibit.
- Investors should refer to the full presentation on Indivior's IR page for details.

## SEC filing metadata
- accession: 0001193125-25-132699
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2025-06-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000119312525132699/0001193125-25-132699-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000119312525132699/d949841d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-132699
- JSON: https://secwatch.observer/filing/0001193125-25-132699.json
- Plain text: https://secwatch.observer/filing/0001193125-25-132699.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.